Literature DB >> 10695483

Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches.

J Ruef1, K Peter, T K Nordt, M S Runge, W Kübler, C Bode.   

Abstract

The initiating event of atherogenesis is thought to be an injury to the vessel wall resulting in endothelial dysfunction. This is followed by key features of atherosclerotic plaque formation such as inflammatory responses, cell proliferation and remodeling of the vasculature, finally leading to vascular lesion formation, plaque rupture, thrombosis and tissue infarction. A causative relationship exists between these events and oxidative stress in the vessel wall. Besides leukocytes, vascular cells are a potent source of oxygen-derived free radicals. Oxidants exert mitogenic effects that are partially mediated through generation of growth factors. Mitogens, on the other hand, are potent stimulators of oxidant generation, indicating a putative self-perpetuating mechanism of atherogenesis. Oxidants influence the balance of the coagulation system towards platelet aggregation and thrombus formation. Therapeutic approaches by means of antioxidants are promising in both experimental and clinical designs. However, additional clinical trials are necessary to assess the role of antioxidants in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695483

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.

Authors:  Zheng Sun; Shirley Zhang; Jefferson Y Chan; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

2.  Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response.

Authors:  Zheng Sun; Y Eugene Chin; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

3.  KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response.

Authors:  Zheng Sun; Tongde Wu; Fei Zhao; Alexandria Lau; Christina M Birch; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

4.  Antioxidants and cardiovascular disease: Still a topic of interest.

Authors:  Shuko Nojiri; Hiroyuki Daida; Yutaka Inaba
Journal:  Environ Health Prev Med       Date:  2004-09       Impact factor: 3.674

5.  Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro.

Authors:  Zhengyu Pang; Laura E Niklason; George A Truskey
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

6.  Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons.

Authors:  Xing Li Wang; David L Rainwater; Michael C Mahaney; Roland Stocker
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

7.  Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response.

Authors:  Zheng Sun; Zheping Huang; Donna D Zhang
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

8.  Increased plasma thioredoxin in patients with acute myocardial infarction.

Authors:  Hirofumi Soejima; Hisakazu Suefuji; Shinzo Miyamoto; Ichiro Kajiwaram; Sunao Kojima; Jun Hokamaki; Tomohiro Sakamoto; Michihiro Yoshimura; Hajime Nakamura; Junji Yodoi; Hisao Ogawa
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

Review 9.  New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart.

Authors:  Yoshiyuki Ikeda; Sebastiano Sciarretta; Narayani Nagarajan; Speranza Rubattu; Massimo Volpe; Giacomo Frati; Junichi Sadoshima
Journal:  Oxid Med Cell Longev       Date:  2014-07-15       Impact factor: 6.543

Review 10.  Lactoferrin in a Context of Inflammation-Induced Pathology.

Authors:  Marian L Kruzel; Michal Zimecki; Jeffrey K Actor
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.